Grifols (GIKLY) Other Non-Current Assets (2009 - 2025)

Grifols (GIKLY) posted Other Non-Current Assets of $27.9 million for Q4 2025, down 31.2% quarter-over-quarter from $40.6 million in Q4 2024, and down 31.2% year-on-year from $40.6 million in Q4 2024.

Grifols (GIKLY) Other Non-Current Assets (2009 - 2025) Analysis & Trends

Grifols (GIKLY) has reported Other Non-Current Assets for 15 consecutive years, with $27.9 million the latest figure, recorded in Q4 2025.

  • Other Non-Current Assets for Q4 2025 came in at $27.9 million, down 31.2% year-over-year; the trailing twelve-month figure through Dec 2025 was $27.9 million (down 31.2% YoY), and the FY2025 annual result was $27.9 million, down 31.2% from the prior year.
  • Other Non-Current Assets was $27.9 million for Q4 2025 at Grifols, down from $40.6 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $298.9 million in Q4 2021 and troughed at $27.9 million in Q4 2025.
  • Average Other Non-Current Assets over 5 years is $128.0 million, with a median of $126.7 million recorded in 2022.
  • Year-over-year, Other Non-Current Assets surged 132.07% in 2021 and plunged 72.17% in 2024.
  • Over 5 years, Other Non-Current Assets stood at $298.9 million in 2021, then tumbled by 57.61% to $126.7 million in 2022, then grew by 15.17% to $145.9 million in 2023, then slumped by 72.17% to $40.6 million in 2024, then plunged by 31.2% to $27.9 million in 2025.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $27.9 million in Q4 2025, $40.6 million in Q4 2024, and $145.9 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 7.23 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 14.11 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 10.54 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 19.81 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 12.76 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 4.55 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 9.83 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - 200.00 Mn
10 Grifols - - - 27.94 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 27.94 Mn
Dec 31, 2024 40.61 Mn
Dec 31, 2023 145.93 Mn
Dec 31, 2022 126.71 Mn
Dec 31, 2021 298.91 Mn
Dec 31, 2020 128.80 Mn
Sep 30, 2020 147.64 Mn
Mar 31, 2020 145.22 Mn
Dec 31, 2019 -15.35 Mn
Sep 30, 2019 133.28 Mn
Mar 31, 2019 137.44 Mn
Dec 31, 2018 2.18 Mn
Sep 30, 2018 78.26 Mn
Jun 30, 2018 10.24 Mn
Mar 31, 2018 75.04 Mn
Dec 31, 2017 77.90 Mn
Jun 30, 2017 5.72 Mn
Dec 31, 2016 1.16 Mn
Sep 30, 2016 -723,287.54
Jun 30, 2016 5.24 Mn